Follow
Mariano Bizzarri
Mariano Bizzarri
professor of biochemistry
Verified email at uniroma1.it - Homepage
Title
Cited by
Cited by
Year
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
M Bizzarri, S Proietti, A Cucina, RJ Reiter
Expert opinion on therapeutic targets 17 (12), 1483-1496, 2013
2152013
Pharmacodynamics and pharmacokinetics of inositol (s) in health and disease
M Bizzarri, A Fuso, S Dinicola, A Cucina, A Bevilacqua
Expert opinion on drug metabolism & toxicology 12 (10), 1181-1196, 2016
1892016
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS
F Facchinetti, M Bizzarri, S Benvenga, R D’Anna, A Lanzone, C Soulage, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 195, 72-76, 2015
1602015
Melatonin and vitamin D3 synergistically down‐regulate Akt and MDM2 leading to TGFβ‐1‐dependent growth inhibition of breast cancer cells
S Proietti, A Cucina, F D’Anselmi, S Dinicola, A Pasqualato, E Lisi, ...
Journal of pineal research 50 (2), 150-158, 2011
1372011
Inositols in insulin signaling and glucose metabolism
A Bevilacqua, M Bizzarri
International journal of endocrinology 2018, 2018
1342018
Modulation of redox status and calcium handling by extremely low frequency electromagnetic fields in C2C12 muscle cells: A real-time, single-cell approach
C Morabito, F Rovetta, M Bizzarri, G Mazzoleni, G Fanò, MA Mariggiò
Free Radical Biology and Medicine 48 (4), 579-589, 2010
1272010
Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells
A Cucina, S Proietti, F D’Anselmi, P Coluccia, S Dinicola, L Frati, ...
Journal of pineal research 46 (2), 172-180, 2009
1242009
Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells
S Proietti, A Cucina, G Dobrowolny, F D'Anselmi, S Dinicola, MG Masiello, ...
Journal of pineal research 57 (1), 120-129, 2014
1172014
Fractal analysis in a systems biology approach to cancer
M Bizzarri, A Giuliani, A Cucina, F D’Anselmi, AM Soto, C Sonnenschein
Seminars in cancer biology 21 (3), 175-182, 2011
1172011
Antiproliferative and Apoptotic Effects Triggered by Grape Seed Extract (GSE) versus Epigallocatechin and Procyanidins on Colon Cancer Cell Lines
S Dinicola, A Cucina, A Pasqualato, F D’Anselmi, S Proietti, E Lisi, ...
International journal of molecular sciences 13 (1), 651-664, 2012
1162012
Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
M Bizzarri, A Cucina
1142014
Inositol: history of an effective therapy for Polycystic Ovary Syndrome
CG Bizzarri M.
European Review for Medical and Pharmacological Sciences 18, 1896-1903, 2014
1132014
Theoretical aspects of systems biology
M Bizzarri, A Palombo, A Cucina
Progress in biophysics and molecular biology 112 (1-2), 33-43, 2013
1092013
The rationale of the myo‐inositol and D‐chiro‐inositol combined treatment for polycystic ovary syndrome
S Dinicola, TTY Chiu, V Unfer, G Carlomagno, M Bizzarri
The Journal of Clinical Pharmacology 54 (10), 1079-1092, 2014
1052014
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology–assisted reproduction technology
A Bevilacqua, G Carlomagno, S Gerli, M Montanino Oliva, P Devroey, ...
Gynecological Endocrinology 31 (6), 441-446, 2015
1032015
Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders
S Dinicola, M Minini, V Unfer, R Verna, A Cucina, M Bizzarri
International journal of molecular sciences 18 (10), 2187, 2017
1022017
Molecular mechanisms of melatonin’s inhibitory actions on breast cancers
S Proietti, A Cucina, RJ Reiter, M Bizzarri
Cellular and molecular life sciences 70, 2139-2157, 2013
1022013
Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey
AS Laganà, G Veronesi, F Ghezzi, MM Ferrario, A Cromi, M Bizzarri, ...
Open Medicine 17 (1), 475-484, 2022
1012022
Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients
G Monastra, V Unfer, AH Harrath, M Bizzarri
Gynecological Endocrinology 33 (1), 1-9, 2017
1012017
Beyond the oncogene paradigm: understanding complexity in cancerogenesis
M Bizzarri, A Cucina, F Conti, F D’anselmi
Acta biotheoretica 56, 173-196, 2008
1002008
The system can't perform the operation now. Try again later.
Articles 1–20